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Available online 17 September 2016Background/objectives: Carotid intimal media thickness (IMT) and coronary calcium scores (CCS) are thought to
reﬂect atherosclerotic burden. The validity of this assumption for IMT is challenged by recent meta-analyses; for
CCS by absence of a relationship between negative scores, and freedom of future events. As such, we considered
evaluation of the relationship between tissue IMT and CCS, and extend of atherosclerotic disease relevant.
Methods: Analyses were performed on donor aortas obtained during renal graft procurement, and on coronary
arteries collected during heart valve procurement for tissue donation. Movat pentachrome and Hematoxylin
stainingwas performed, and the degree of atherosclerosis histologically graded. IMT and presence of calcium de-
posits were quantiﬁed on graded tissue sections.
Results: 304 aortas and 185 coronary arteries covering the full atherosclerotic spectrum were evaluated. Aortas
and coronaries showed similar relationships between tissue IMT and degree of atherosclerosis, with gradual in-
crease in tissue IMT during earlier phases of atherosclerosis (r= 0.68 and r= 0.30, P b 0.00001 for aorta and cor-
onaries respectively), followed by plateauing of the curve in intermediate and advanced stages. Results for tissue
IMT reveal high variability, resulting in wide conﬁdence intervals. Results for CCS are similar for aorta and coro-
naries, with calcium depositions limited to advanced lesions.
Conclusions:Histological IMTmeasurements for the aorta and coronaries show large variations around the trend
and plateauing of, and possibly reductions in IMT in late stage atherosclerotic disease. These observations for the
aorta and coronaries may (partly) explain the limited beneﬁt of including carotid IMT in risk prediction
algorithms.
© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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Histology1. Background/objectives
Although the value of conventional cardiovascular risk factors for in-
dividual risk assessment has been ﬁrmly established, most cardiovascu-
lar events occur in patients not classiﬁed at increased risk by using
current risk algorithms. As a consequence, there is a strong need for
complementary individual risk prediction tools.
Carotid intimal media thickness (IMT) and coronary calcium scores
(CCS) emerged as epidemiological measures of atherosclerotic burdenoronary calcium scores; AHA,
in stain; AIT, Adaptive Intimal
ntimal Thickening; EFA, early
oatheroma; PR, plaque rupture;
6-R, Leiden University Medical
dered as ﬁrst author.
land Ltd. This is an open access articl[1,2]. Yet, thesemeasures are also progressively advocated as individual
risk prediction tools [3,4] and changes in carotid IMT are now used as
surrogate endpoints in clinical trials aimed at stabilizing or reversing
the atherosclerotic disease [5,6].
Paradoxically, a number of prominent meta-analyses fail to demon-
strate an additional beneﬁt of including carotid IMT in existing risk algo-
rithms, thereby challenging the value of carotid IMT as an individual risk
marker [6–9]. Studies on the validity of CCS as a personalized risk strat-
iﬁcation tool point to a low predictive value of a negative CCS; [10] a
limitation thought to reﬂect absence of an association between calciﬁca-
tion and plaque characteristics [11].
In this context, it is important to note that manifestations of athero-
sclerotic disease (i.e. myocardial infarction and stroke) are caused by
qualitative changes in the plaque structure (plaque rupture) [12,13],
rather than by quantitative changes in plaque volume. In fact, it has
long been established that the degree of stenosis poorly relates to future
events [14,15]. As such the value of the quantitative imaging tool IMT
and the presumably late qualitative marker CCS critically depend one under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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[13,16].
Given the emerging limitations of carotid IMT and CCS for individual
risk prediction, we considered a direct validation of an association be-
tween IMT and CCS, and qualitative aspects of atherosclerotic disease
progression relevant. Such an evaluation is obviously not feasible in
the clinical setting in which there is no access to the actual tissue. In
order to test a putative association between the grade of atherosclerosis,
and IMT and calciumscoreswedirectly assessed IMT andCCSon arterial
wall sections from two unique vascular tissue banks that cover the full
spectrum of aortic and coronary atherosclerosis.
2. Materials and methods
2.1. Patients and tissue sampling
Sample collection and handling was performed in accordance with the guidelines of
the Medical and Ethical Committee of the Leiden University Medical Center, the
Netherlands, and the code of conduct of the Dutch Federation of Biomedical Scientiﬁc So-
cieties. Due to national regulations, only for transplantation relevant data fromdonorswas
available for research (http://www.federa.org/codes-conduct).
This study includes data from 304 consecutive aorta samples from as many donors
collected during kidney transplantation, and from 185 consecutive left coronary artery
samples from asmany donors collected during aortic valve harvesting for tissue donation.
Due to the implied age restrictions maximum age of the aortic valve donors was 65 years.
No formal age restrictions apply to kidney donations, as such this group also includes older
patients.
Aortic patches (from the level of the renal artery) were obtained during kidney trans-
plantation procedures. During the donation procedure the donor kidney including the
renal artery is removed alongwith a large part of the adjoining aorta. Prior to transplanta-
tion the aorta is removed and the renal artery trimmed to the required length. The donor-
derived aortic segments are not required for transplantation and used for further studies.
Aneurysmal aortas (circumference N 2.5 cm, n= 2)were excluded from the study. All do-
nors met the Eurotransplant criteria [17].
The left coronary artery segments were collected from healthy human hearts that
were retrieved from Dutch postmortem donors within 24 h after circulation stop and
brought to the Heart Valve Bank Rotterdam for heart valve donation. All donors gave per-
mission for research, and met the criteria maintained by the Dutch Transplantation
Foundation.
In the donation procedure the aortic valve is removed from the donated heart. During
further aortic valve preparation the adjacent left coronary artery is trimmed according to
standard procedures. Small segments of the left coronary artery were collected especially
for this study, without hampering the pathological analysis of the heart necessary for re-
lease of the harvested valves.
2.2. Histological classiﬁcation of lesions
All material was formaldehyde ﬁxed and decalciﬁed (Kristensen's solution). All aorta
patches and coronary arteries were divided in consecutive 5 mm segments, parafﬁn em-
bedded, and 4 μm sections were prepared from each segment. Sections were Movat
pentachrome and H&E stained and classiﬁed according to the revised classiﬁcation of
theAmericanHeart Association (AHA) as proposedbyVirmani cs. [16,17] by two indepen-
dent observerswith no knowledge of the donor characteristics. Although all sampleswereFig. 1.Movat Pentachrome (top) and Hematoxylin Eosin (H&E) staining (bottom) of atherosc
Virmani classiﬁcation system for atherosclerosis. Pathological Intimal Thickening (PIT) is char
(LFA) presents with a large necrotic containing multiple cholesterol crystals and that is covere
with a single, condensed calciﬁed area [16]. Decalciﬁcation does not interfere with CCS scorin
purple deposits) or Movat staining (brown and dark purple deposits in the detail (20-fold, righdecalciﬁed in order to allow processing of the samples. Decalciﬁcation does not interfere
with CCS scoring as footprints of earlier calcium deposits can easily be recognized in
H&E staining (dark purple deposits) or Movat staining (brown and dark purple deposits)
(Fig. 1). For each individual the tissue section showing the most advanced degree of ath-
erosclerosis was used as reference section for further studies, viz. each sample in the
study is from a different individual.
A thin cap ﬁbroatheroma (TCFA) was deﬁned as a ﬁbrous cap less than 155 μm thick
(aorta) [17] or less than 65 μm thick (coronary) [18]. Note that multiple lesions and lesion
typesmay be present in a single section. Because of the low number of TCFAs, Plaque Rup-
tures (PR) and Healed Ruptures (HR) in the coronaries, we also included readings from
these stages from sections in which more advanced stages were also present.
2.3. Morphological and histological analysis
Morphometric and histological analysis were performed on Movat pentachrome
stained sections with Image J calibrated software (http://imagej.nih.gov/ij/) [17]. Tissue
IMT was measured perpendicular to the lumen on 4 locations in the area showing the
maximum IMT. A positive CCS (H&E staining) was deﬁned by presence of a calciﬁed
area of minimal 200 μm. This lower cut-off value was chosen as it reﬂects the resolution
of high-end CT scanning.
2.4. Statistical analysis
Statistical analysis was performed using SPSS 20 (IBM, Amsterdam, the Netherlands).
Data in ﬁgures is presented asmedianswith IQR. Spearman's rho test was used to demon-
strate the relation between IMT and the atherosclerotic stage. To that end the lesion type
was reclassiﬁed in a numeric score (normal = 0…, FCP = 9). ANOVA and Kruskal-Wallis
followedby post-hoc analysis (LSD andMann-Whitney respectively)were used to test po-
tential differences in respectively IMT and CalciumScores, and the individual stages of ath-
erosclerosis. ANOVA and co-variance analysis was performed to test the inﬂuence of age
and sex on the IMT readings. P values b 0.05 were considered signiﬁcant.
3. Results
3.1. Studied population
Details on the study populations are provided in Table 1 (donor
characteristics of the kidney donor (aortic patch)) and Table 2 (aortic
valve donor (left coronary artery)).
3.2. Classiﬁcation of atherosclerotic disease
Representative images illustrating the atherosclerosis grading sys-
tem are shown in Fig. 1. The distribution of most advanced lesion
types, and the relationships with donor age and sex are shown in
Fig. 2 (aorta) and Fig. 3 (coronary artery). Clear differences were
found between aortic and coronary segments with respect to the distri-
bution pattern of the dominant lesion type (Figs. 2 and 3), with regard
to a low prevalence of so-called (pre)vulnerable lesions (viz. Late
Fibro Atheroma, TCFA and PRs) and a high prevalence of so calledlerotic lesions in different aortic lesions. Representative images illustrating aspects of the
acterized by presence of a an acellular lipid pool in the outer intima. Late Fibroatheroma
d by a ﬁbrous cap. A Fibrous Calciﬁed Plaque (FCP) represent represents a ﬁbrotic lesion
g as footprints of earlier calcium deposits can easily be recognized in H&E staining (dark
t)).
Table 1
Donor characteristics (aorta, mean (sd)).
Male
N = 156
Female
N = 145
Age (yrs) 45.2 (17.5) 44.6 (15.7)
BMI (kg/m2) 24.8 (3.6) 23.5 (4.4)
Cause of death (n)
Cerebrovascular accident 34 29
Subarachnoid hemorrhage 32 56
Head trauma 47 21
Cardiac arrest 7 4
Myocardial infarction 1 0
Suffocation 5 3
Pulmonary embolism 0 1
Other/not speciﬁed 30 31
Antihypertensive use 20 18
Statin use 6 1
Fig. 2. Histological classiﬁcation of human aortic atherosclerotic lesion type, and the
relationship to age and sex. Three hundred and four aortic patches were characterized
for the type of atherosclerosis according to Virmani et al. [16] and classiﬁed on basis of
the highest degree of atherosclerosis present. The graph shows the highest grade of
aortic atherosclerosis in relation to the age of the donor. There is a signiﬁcant correlation
of lesion type with age (r = 0.640, P = 0.01). Abbreviations; AIT: Adaptive Intimal
Thickening, IX: Intimal Xanthoma, PIT: Pathological Intimal Thickening, EFA: Early
Fibroatheroma, LFA: Late Fibroatheroma, TCFA: Thin Cap Fibroatheroma, PR: Plaque
Rupture, HR: Healing Rupture, FCP: Fibrotic Calciﬁed Plaque.
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tery group.
3.3. Distribution of tissue IMT and stages of atherosclerosis
Fig. 4 shows the relationship between tissue IMT and the aortic le-
sion type. A positive relationship is found during lesion initiation and
early progression (r = 0.68, P b 0.00001), but the curve plateaus in
the advanced, vulnerable lesions (TCFA, PR and HR) and the stabilized
lesions (HR and FCP). Results for the coronary artery segments (Fig. 5)
follow those of the aorta and show an increase in tissue IMT in the
early phases (r = 0.30, p b 0.00005) of the disease, plateauing of tissue
IMT in the advanced and stabilized lesions. Along these lines clear differ-
ences were found between the individual stages of atherosclerosis
(ANOVA: Aorta: P b 2.1 10−37; Coronary: P b 2.9 10−16, differences be-
tween the individual stages are shown in Tables 3A and 3B). The varia-
tion around the trend is high, thus resulting inwide conﬁdence intervals
(conﬁdence intervals are indicated in Figs. 4 and 5).
3.4. Distribution of calcium scores
Calcium deposits are absent in normal arteries and the early phases
of atherosclerotic disease. Relevant calcium deposits start to appear in a
minority of the LFAs and the prevalence rapidly increases thereafter
(Kruskal-Wallis: Aorta: P b 6.5 10−29; Coronary: P b 2.5 10−16), and rel-
evant calciﬁcation deposits are found in 75% (P b 0.002) and 96%
(P b 0.00006) of the aortic and coronary FCPs respectively. Although cal-
ciﬁed plaques are often considered stabilized lesions, we observed signs
of instability such as penetrating calciﬁed lesions (i.e. eroded calciﬁed
lesions (Fig. 6A) or newly forming lesions over old calciﬁed lesions,
Fig. 6B).Table 2
Donor characteristics (left coronary artery, mean (sd)).
Male
N = 99
Female
N = 87
Age (yrs) 48.8 (12.4) 53.4 (9.6)
BMI (kg/m2) 25.9 (3.3) 25.5 (4.3)
Cause of death (n)
Cerebrovascular accident 18 11
Sub-archnoidal hemorrhage 8 22
Head trauma 16 11
Cardiac arrest 12 4
Myocardial infarction 27 19
Suffocation 7 9
Pulmonary embolism 4 5
Other/not speciﬁed 9 6
Antihypertensive use (n) 29 40
Statin use (n) 19 153.5. Ageing and IMT
Age is a co-variant of the atherosclerotic disease and has been
brought forward as a potential confounder of IMT. We used to two dif-
ferent strategies to test the effect of age on tissue IMT in the aortic sam-
ples. In the ﬁrst approach we sought for an association between tissue
IMT and age in adult patients (with non-pathological intimal thickening
(i.e. normal, adaptive intimal thickening and intima xanthoma) through
simple regression analysis. The analysis showed a moderate correlation
between age and tissue IMT (r = 0.335; adjusted r2 = 0.083) and bor-
derline signiﬁcance in the ANOVA (P= 0.057). The second analysis was
based on co-variant analysis on the full cohort. This approach showed
that correction for age and sex minimally inﬂuences the estimates
(Table 4).4. Conclusions
This study evaluates putative associations between IMT and calcium
scores, and atherosclerotic disease progression (histological plaque
characteristics deﬁned on themodiﬁedAHA classiﬁcation) in vesselma-
terial obtained during organ/tissue donation, viz. material from the
donor. Results conﬁrm an association between tissue IMT and plaque
progression, but also show plateauing and even reductions in tissueFig. 3. Histological classiﬁcation of human coronary artery atherosclerotic lesion type and
the relationship to age and sex. One hundred eighty ﬁve coronary samples were
characterized for the type of atherosclerosis according to Virmani et al. [16] and
classiﬁed on basis of the highest degree of atherosclerosis present. The graph shows the
highest grade of aortic atherosclerosis in relation to the age of the donor. There is a
signiﬁcant correlation of lesion type with age (r = 0.30, P = 0.00005). Abbreviations are
deﬁned in the legend of Fig. 1.
Fig. 4. Aortic IMT and CS versus the grade of atherosclerosis. Relations between histological
IMT (the thick line represents the median IMT, dispersion around the median is shown by
the 5th, 25th, 75th and 95th percentile lines). Presence of detectable (deﬁned by presence
of at least one or more calcium aggregates N200 μm) is indicated by the robust dashed
line; and the dominant aortic atherosclerotic lesion type). Abbreviations are deﬁned in the
legend of Fig. 2.
Fig. 5. Coronary IMT and CS versus the grade of atherosclerosis. Relations between
histological IMT (the thick line represents the median IMT, dispersion around the
median is shown by the 5th, 25th, 75th and 95th percentile lines). Presence of
detectable (deﬁned by presence of at least one or more calcium aggregates N200 μm in
the lesion; indicated by the robust dashed line), and the dominant atherosclerotic lesion
type. Abbreviations are deﬁned in the legend of Fig. 2.
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large variability in tissue IMT, thereby resulting in wide conﬁdence in-
tervals around the trend. Results for the CCS conﬁrm data from
Mauriello et al. [11] and characterize CCS as a marker of advanced and
end-stage atherosclerotic disease.
Carotid IMT is nowwidely accepted as a screening tool to detect ath-
erosclerosis in the early and asymptomatic stages of the disease. Indeed
IMT has been adopted by the AHA as a surrogate marker for coronaryTable 3A
P-values for a comparing of aortic IMT between the different stages (LSD post-hoc test).
Normal AIT IX PIT
AIT 0,051462
IX 0,013681 0,450608
PIT 7,43E−06 9E−05 0,000966
EFA 2,18E−09 1,74E−09 2,71E−08 0,004753
LFA 2,9E−12 3,98E−13 6,24E−12 6,59E−06
TCFA 2,51E−15 2,65E−17 4,17E−16 2,64E−09
RP 5,48E−15 1,96E−16 2,91E−15 6,81E−09
HR 1,49E−15 3,2E−17 4,76E−16 1,55E−09
FCP 3,63E−12 1,5E−12 2,06E−11 6,9E−06artery disease [1]. In addition to its use as a screening tool, carotid IMT
evolved as a surrogate endpoint in trials monitoring the effectiveness
of pharmaceutical interventions aimed at reducing atherosclerotic pro-
gression and cardiovascular risk [5,6]. Notwithstanding the broad rec-
ognition of carotid IMT as a complementary risk prediction tool, large
epidemiological evaluations shed doubt on the validity of carotid IMT
as an individual risk prediction tool [7–9]. In fact these recent evalua-
tions only indicate a modest or fail to show a beneﬁt of including IMT
in risk prediction algorithms. In fact, a large meta-analysis concluded
that “The addition of common CIMT (carotid IMT) measurements to
the Framingham Risk Score was associated with small improvement
in 10-year risk prediction of ﬁrst-time myocardial infarction or stroke,
but this improvement is unlikely to be of clinical importance” [8].
Along similar lines a 2012 AHA position statement denounced the use
of CCS and carotid IMT for screening the asymptomatic adult population
for CHD [10]. These observations are remarkable and imply that the
added value of IMT is less than commonly thought and that individual-
ized use of IMT is challenged.
A possible explanation for the limited additional beneﬁt of including
IMT in established risk algorithms is the fact that IMT is a pure quantita-
tive measure, and therefore may not necessarily reﬂect the atheroscle-
rotic disease process. Moreover, it has been pointed out that increases
in IMT are a consequence of the aging process, and thus that increased
IMT could simply reﬂect physiologic, ageing-related thickening of the
intimal-medial layers [19]. On the other end of the spectrum, it is well
established that the degree of luminal stenosis caused by plaque growth
poorly predicts future cardiovascular events [14,15]. In this context it is
important to note that atherosclerosis is a multi-stage disease process
that evolves through successive stages of intimal lipid accumulation,
plaque formation and progression, followed by plaque destabilization
and plaque rupture, and ﬁnally plaque stabilization [12,13]. It is now as-
sumed that plaque destabilization is the pivotal factor in the develop-
ment of insidious manifestations of the disease.
At this point it is unclear how and towhat extent IMT readings trans-
late to the process of plaque evolution, destabilization and subsequent
stabilization. In order to assess such a relationship, we considered a sys-
tematic evaluation of a possible relationship between IMT and plaque
characteristics relevant. To that end we performed a systematic evalua-
tion of a putative association between intimal media thickness directly
measured on tissue slides (tissue IMT) and histological grading in two
large biobanks of human vascular tissue.
In the ideal world situation such a study would be performed on ca-
rotid tissue. Yet, available biobanks of carotid tissue are all based on sur-
gical specimens of carotid endarteriectomies; hence representing end-
stage atherosclerotic disease and, depending on the depth of the
-tomy missing segments of the medial layer. In order to be able to
cover the full atherosclerotic spectrum, and the obvious need for an in-
tactmedia (hence full thickness samples)we decided for a study onma-
terial collected during transplantation procedures (i.e. intact arterial
tissue).
The ﬁrst series of studies was performed on donor material from
a biobank of aortic segments [17]. These donor aortic segments
come with the kidney graft and are (partially) removed duringEFA LFA TCFA RP HR
0,0658
0,000907 0,14849
0,000975 0,132691 0,912142
0,000403 0,082835 0,735055 0,825458
0,042112 0,767626 0,281548 0,251151 0,171564
Table 3B
P-values for a comparing of coronary IMT between the different stages (LSD post-hoc test).
Normal AIT IX PIT EFA LFA TCFA/RP HR
AIT 0,529884
IX 0,34549 0,622489
PIT 0,030391 0,016838 0,11385
EFA 0,010435 0,004541 0,034858 0,39813
LFA 1,68E−06 4,6E−09 6,15E−07 1,33E−05 0,001224
TCFA/RP 0,00019 4,36E−05 0,000438 0,006783 0,048938 0,524844
HR 8,67E−06 1,53E−08 3,24E−06 7,48E−05 0,007026 0,392468 0,998496
FCP 1,75E−06 1,25E−11 8,33E−08 5,52E−07 0,001492 0,302046 0,979117 0,969555
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atherosclerotic disease; although its large local diameter generally pre-
cludes clinical manifestations [17]. An obvious question is whether
these observations from an elastic artery such as the aorta are also
valid for other arterial beds. We therefore validated the ﬁndings for
the aorta on material from a second biobank based on donor coronary
arteries that were collected during aortic valve procurement for tissue
donation. Although this material is from an obviously more relevant ar-
terial bed,material in this bank ismore circumscribed due to stricter age
restrictions (maximum age for aortic valve donation is 65), and the fact
that hearts from younger/healthier donors are more likely to be allocat-
ed for whole organ donation. Hence, it's likely that material in this
biobank is less representative to the general population than the mate-
rial in the aorta-based biobank.Fig. 6. Instable lesions in calciﬁed coronaries. A:Movat pentachrome staining showing a rupture
this single cross section and the formation of a new lesion (neo atherosclerosis, greenish pro
(detail). The defect in the upper right corner reﬂects a cutting artifact. B: Movat Pentachrome
underlying area and an extremely thin, a-cellular overlying cap (12.5 fold (overview), a
proteoglycans, yellow: collagen, black: elastin, red: smooth muscle cells and ﬁbrinogen, purpleWeclassiﬁed all donormaterial in our study according to themodiﬁed
AHA classiﬁcation as proposed by Virmani et al. [16]. This classiﬁcation is
thought to better differentiate between the more advanced stages of the
atherosclerotic process, and unlike the AHA classiﬁcation it has a contin-
uous (progressive) association between disease progression and score.
Classiﬁcation was performed on basis of the Movat staining as this stain-
ing allows for clear differentiation between the different advanced lesions
(in particular late ﬁbroatheroma and ﬁbrous calciﬁed lesion).
A systematic evaluation in the aortic tissue bank shows that athero-
sclerotic disease is very common among those over 40 years of age, and
that unstable plaques and healed plaques (FCP) are present in 7% of the
donors. Results for the coronary artery segments roughly followed those
for the aorta, although the very limited availability of material from do-
nors under the age of 30 interferes with ﬁrm conclusions on a possibledﬁbrous cap overlying a small calciﬁednodule (circle). Note presence ofmultiple lesions in
teoglycan/collagen rich area, arrow) (12.5 fold (overview), and 100 times magniﬁcation
staining showing a penetrating calcium nodule. Note the complete loss of media in the
nd 40-fold magniﬁcation (detail)). Note: color legend for the Movat staining: blue:
: nuclei. Green reﬂects co-localization of proteoglycans and collagen.
Table 4
Plain regression coefﬁcients and corrected (age and sex) regression coefﬁcients in adult
donors (age N 20 years) for the association between IMT and the stage of atherosclerosis.
Uncorrected Corrected
AIT 0.27 (0.14) 0.24 (0.14)
IX 0.33 (0.13) 0.31 (0.14)
PIT 0.61 (0.13) 0.55 (0.15)
EFA 0.87 (0.14) 0.81 (0.16)
LFA 1.07 (0.15) 1.02 (0.17)
TCFA 1.25 (0.15) 1.22 (0.17)
RP 1.26 (0.15) 1.22 (0.17)
HR 1.29 (0.15) 1.26 (0.18)
FCP 1.11 (0.15) 1.01 (0.18)
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classical lesions (early and late ﬁbroatheroma) and instable lesions, and
the high prevalence of ﬁbrous calciﬁed lesions in coronary arteries (32%
of the specimenswere classiﬁed as a FCP). Although lack of longitudinal
data interferes with ﬁrm conclusions, these observations may indicate
that plaque destabilizing in the coronary arteries is a relative rapid pro-
cess and that asymptomatic plaque rupture and subsequent healing, as
reﬂected by the high prevalence of FCPs, is a very common phenome-
non, even in individuals as young as 40–50 years.
IMTmeasurements performed on the tissue slices conﬁrm a positive
relationship between tissue IMT and the histologic classiﬁcation of ath-
erosclerosis. Yet, the data also show ﬂattening, and possibly even a de-
cline in tissue IMT in the vulnerable and particularly stabilized lesions.
This phenomenon challenges the use of sequential IMT measurements
as surrogate end-point in interventional studies as disease regression
or progression may occur in the absence of changes in IMT, or alterna-
tively that reductions in IMT can reﬂect regression or progression.
Such a conclusion is supported by clinical evidence failing to character-
ize IMT as a dynamic marker [20].
The number of tissue samples in our study also allowed for the es-
tablishment of conﬁdence intervals, which indicate a marked variation
in tissue IMT around the trend. These wide conﬁdence intervals pro-
foundly interfere with the interpretation of individual measurements,
thus challenging the use of IMT for personalized care and (partly)
explaining the limited value of including IMT in risk algorithms.
Results for histological assessment of CCS herein follow the conclu-
sions of Mauriello et al. [11] and show that calcium deposits reﬂect
the later stages of the disease, and are particularly prominent in the so
called stabilized lesions. This observation supports the notion that calci-
um deposits are associated with end stage, stabilized lesions. Yet, we
found indications that penetrating ulcers can develop in the ﬁbrous
cap overlying a calcium nodule (Fig. 5). Moreover, new lesions can de-
velop on top of extinguished lesions, resulting in a repetitive process
of plaque healing, followed by formation and destabilization of a new
plaque over the existing paciﬁed lesion (Fig. 5). Formed buried lesions
show that calcium deposits persist for extended periods of time, and
hence that calcium scores largely reﬂect the past.
All in all, results for calciumdeposits suggest that CCS should be con-
sidered a retrospective marker, identifying patients with manifest ath-
erosclerotic disease, whereas a negative calcium score does not rule
out presence of atherosclerotic disease. The apparent persistence of cal-
cium implies a very low clearance rate, hence disqualifying calcium
scores as a dynamic marker.
Limitations: For practical reasons outlined above we were unable to
evaluate a relation between carotid IMT and qualitative measures of ca-
rotid atherosclerosis. Yet, given the established relation between carotid
IMT and coronary readings we consider our ﬁndings from the aorta and
coronary arteries relevant for the carotid bed [1]. A second limitation is
that measurements are performed on parafﬁn embedded tissue sec-
tions. As such, we were able to use clear anatomical land marks for
the tissue IMT. It is unknown how these actual landmarks translated
to the contrast-based deﬁned landmarks used in B-mode ultrasound[21]. Another point is that the process of tissue preparation for histology
involves tissue shrinkage due to intrinsic tissue contractility as well as
due to the dehydration process required for parafﬁn embedding [22].
As such measures in the study are relative, and do not translate one to
one with the real-life situation. Moreover, we cannot exclude that
shrinkage may be less in more ﬁbrotic tissues such as the FCP lesion
type. As such our data may underestimate the apparent decline in IMT
during plaque stabilization. Finally, we observed a low number of vul-
nerable lesions in our set of coronary arteries; hence conclusions for
this stage should be interpreted with caution.
In conclusion, this histological evaluation shows a weak association
between histological IMT and the atherosclerotic process. Extremely
wide conﬁdence intervals interfere with the interpretation of individual
data, whereas ﬂattening or possible even declining IMT values may se-
verely compromise interpretation of sequential IMT in the context of in-
tervention studies. Consequently, on basis of our observations for the
aorta and coronaries IMT cannot be recommended as a qualitativemea-
sure of atherosclerosis. Findings for the calcium deposits show that cal-
cium deposition occurs late in the process and the calcium deposits are
stable. As such, CCS do not qualify as a dynamic marker and largely re-
ﬂect the past. Consequently, positive CCS identify those patients with
manifest advanced atherosclerotic disease.
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